{"denoms":[{"counts":[{"groupId":"BG000","value":"1280"}],"units":"Participants"}],"groups":[{"description":"All participants received up to four 21-day cycles of cisplatin-based chemotherapy (cisplatin plus either vinorelbine or docetaxel or gemcitabine or pemetrexed \\[non-squamous cell NSCLC only\\] based on investigator's choice), unless unacceptable toxicity, disease relapse, or participant's decision to discontinue occurred.","id":"BG000","title":"Enrollment Phase"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.7","value":"61.4"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"427"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"853"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"1219"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"43"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"307"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"8"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"935"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"27"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Enrolled population was defined as all eligible participants who were enrolled in the enrollment phase, regardless if they are subsequently randomized or not."}